Explorer

UK’s Imperial College Coronavirus Vaccine Candidate Enters Second Phase Of Clinical Trials

Clinical trials for the coronavirus vaccine candidate by the Imperial College, UK has expanded and it will now be tested on 300 people.

New Delhi: A coronavirus vaccine candidate created by UK’s Imperial College is going to start testing on 300 people including people over 75. The vaccine is designed synthetically and doesn’t contain any particles of the virus, unlike other vaccine candidates. This new ‘self-amplifying RNA’ vaccine technology is been developed by Professor Robin Shattock and his team at Imperial’s Department of Infectious Disease. ALSO READ| Coronavirus Update: Over 55K New Cases In India; A Look At States Which Reported Maximum Infections According to a statement by Imperial College’s article, the vaccine “uses the genetic instructions for the surface protein of the virus that can’t cause disease on its own…these RNA instructions are put inside a fat droplet and injected into the muscle in your arm. It then instructs your cells to produce copies of that protein for a period of time, allowing your immune system to learn to recognise the virus’s surface spikes. It is hoped this will provide protection again COVID-19 if you come into contact with the coronavirus for real.” The team found no side effects in the initial testing which began earlier this month. Now the team is moving towards testing the vaccine on a larger group. The team is moving slowly but steadily and hopes to have enough safety data to start inoculating on over a thousand people in October. “It’s well-tolerated. There aren’t any side effects,” said Dr. Robin Shattock, a professor at the college, in a report by The Associated Press The team is looking to start trials elsewhere as the cases in Britain have dropped and to see whether the vaccine is effective or nor is becoming increasingly difficult. This vaccine could change the future of immunization, according to the article “The new technology behind this work will allow scientists to quickly develop new vaccines. As soon as the genetic code of new pathogens has been sequenced, scientists will be able to ‘plug in’ instructions for the equivalent of the coronavirus’s surface proteins, to create a new vaccine… enable us to respond more quickly to changing or emerging diseases.
View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headline

LS Elections: Shinde Faction Of Shiv Sena Names First 8 Candidates, Gives Ticket To Rahul Shewale, Hemant Patil
LS Elections: Shinde Faction Of Shiv Sena Names First 8 Candidates
PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
Actor Govinda Joins Eknath Shinde's Shiv Sena, Likely To Contest From Mumbai North West
Actor Govinda Joins Eknath Shinde's Shiv Sena, Likely To Contest From Mumbai North West
Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
Advertisement
for smartphones
and tablets

Videos

Bihar Lok Sabha Polls 2024: ABP Exclusive With Papu Yadav, MP No Longer Contesting From PurniaVarun Gandhi Pens Emotional Letter To Pilibhit After Being Denied, Says 'Mai Aapka Hu Aur Rahunga'Delhi Excise Policy Case: With CM Arvind Kejriwal's Arrest, Who Will Run The State | Watch ReportLok Sabha Elections 2024: 'BJP Just Wants To Break The Aam Aadmi Party' says Saurabh Bhardwaj

Photogallery

Embed widget